Lee Tien-Li
SEC insider (Form 3/4/5 filer). CIK 0001940120. Chief Executive Officer at Aardvark Therapeutics, Inc. (AARD). 12 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in SAN DIEGO, CA.
Companies Lee Tien-Li has filed insider reports for
- Aardvark Therapeutics, Inc. (AARD): Director, Officer, 10% Owner, Chief Executive Officer
Lee Tien-Li
CIK: 0001940120
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aardvark Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Feb 9, 2026AARD
Aardvark Therapeutics, Inc.
AwardDirectStock option (right to buy)
203.9K shares- - Dec 11, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect7K shares at avg. $14.48$101K - Oct 15, 2025AARD
Aardvark Therapeutics, Inc.
ExerciseDirect1.2K shares at avg. $4.24$5K - Sep 15, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect3.5K shares at avg. $9.94$35K - Sep 15, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect6.5K shares at avg. $9.51$62K - Sep 12, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect5K shares at avg. $8.50$43K - Sep 11, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect6K shares at avg. $7.82$47K - Sep 10, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseDirect9K shares at avg. $7.91$71K - Aug 28, 2025AARD
Aardvark Therapeutics, Inc.
ExerciseDirect17.2K shares at avg. $4.24$73K - Jun 11, 2025AARD
Aardvark Therapeutics, Inc.
AwardDirectStock option (right to buy)
549.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 9, 2026 | AARD Aardvark Therapeutics, Inc. | Award Stock option (right to buy) | 203,851 | - | - | Direct |
| Dec 11, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 7,000 | $14.48 | $101,395 | Direct |
| Oct 15, 2025 | AARD Aardvark Therapeutics, Inc. | Exercise | 1,229 | $4.24 | $5,211 | Direct |
| Sep 15, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 3,500 | $9.94 | $34,805 | Direct |
| Sep 15, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 6,500 | $9.51 | $61,819 | Direct |
| Sep 12, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 5,000 | $8.50 | $42,516 | Direct |
| Sep 11, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 6,000 | $7.82 | $46,926 | Direct |
| Sep 10, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 9,000 | $7.91 | $71,213 | Direct |
| Aug 28, 2025 | AARD Aardvark Therapeutics, Inc. | Exercise | 17,209 | $4.24 | $72,966 | Direct |
| Jun 11, 2025 | AARD Aardvark Therapeutics, Inc. | Award Stock option (right to buy) | 549,534 | - | - | Direct |
1-10 of 12 transactions